Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-20-041045

Options or other derivatives

  • Director acquired 61,338 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Booth Bruce Director 2020-07-01 Grant or award · Stock Option (Right to Buy) +61,338 $0.31 $19,125 61,338 D
Loading xslF345X03/doc4.xml…